Skip to main content
Combined rituximab and omalizumab promising for refractory bullous pemphigoid
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Combined rituximab and omalizumab promising for refractory bullous pemphigoid
User login
Username
Password
Reset your password
Concept
Lead
score
Biologic Therapy
1
1
Antineoplastic Drug
0
0.77
Monoclonal Antibody
0
0.77
Bullous Pemphigoid
0
0.99
Corticosteroids
0
0.26
Refractory
0
0.26
Remission
0
0.26
Topical Corticosteroid
0
0.22
Patient Safety
0
0.11
Adverse Effects
0
0.1
Blister
0
0.1
Immunoglobulin G (IgG)
0
0.1
Electronic Medical Record
0
0.07
Electronic Health Record (EHR)
0
0.06
Osteoporosis
0
0.06
Specialty
Lead
score
Dermatology
1
1
Pharmacist
0
0.7
Family Medicine/Primary Care
0
0.9
Internal Medicine
0
0.8
Edit Tags